Imaging Diagnosis of Ischemic Stroke Through Multiparametric Magnetic Resonance Angiography Enhanced by NaGdF4 Nanoparticles
Abstract
To develop an ultra-sensitive nanoparticle contrast agent for magnetic resonance angiography (MRA), to establish a highly sensitive imaging method for complicated vascular structures, and to provide imaging evidence for precision diagnosis, treatment, prognosis, and individualized treatment of ischemic stroke.
Methods
A dual-modality MRA contrast agent was prepared through ligand exchange of ultra-small NaGdF4 nanocrystals synthesized via a high temperature method, with biocompatible polyethylene glycol (PEG-dp) ligands. The basic structure, morphology, size distribution, and relaxation rate of the NaGdF4 nano contrast agent were characterized using transmission electron microscopy (TEM), a particle size potential analyzer, and a 7.0 T small-animal MRI scanner. A total of 6 healthy male SPF-grade BALB/c mice were selected and randomly divided into two groups, a NaGdF4 group and a Gd-DTPA group. The mice in the two groups were injected with NaGdF4 nanoparticle contrast agent or clinical Gd-DTPA contrast agent (0.1 mmol Gd3+/kg) via the tail vein. MRA images were obtained using a 7.0 T small animal magnetic resonance imaging system before and after the injection. A total of 6 healthy male SPF-grade Sprague Dawley (SD) rats were selected to establish a right middle cerebral artery occlusion (rMCAO) model to simulate ischemic stroke. The rats were injected with NaGdF4 nano-contrast agent (0.1 mmol Gd3+/kg) via the tail vein. Before and after the injection, brain MRI images of the rats were obtained using a 7.0 T small animal magnetic resonance imaging system. The in vitro and in vivo biological safety of the nano contrast agent was verified through cytotoxicity and hemolysis experiments and HE staining.
Results
Uniform spherical oil-phase NaGdF4 nanocrystals with an average particle size of approximately (4.43 ± 0.46) nm were successfully prepared. After ligand exchange, biocompatible water-phase nanocrystals were obtained with a hydrodynamic size of 16.1 nm and a surface potential of －1.9 mV. The relaxation performance of this nanocrystal contrast agent was significantly superior to that of the clinical contrast agent Gd-DTPA. The longitudinal molar relaxivity rate (r1) of the NaGdF4 nano contrast agent was 8.84 mM−1s−1, while the transverse molar relaxivity rate (r2) was 27.36 mM−1s−1, which were 1.96 times (4.52 mM−1s−1) and 3.37 times (8.13 mM−1s−1) those of Gd-DTPA, respectively. It also demonstrated excellent biocompatibility. NaGdF4-enhanced MRA achieved high-resolution vascular imaging and effectively enabled the differentiation of the ischemic area, infarct core, and ischemic penumbra in an animal model of ischemic stroke.
Conclusion
The multi-parameter MRA based on NaGdF4 nanoparticles provides critical imaging evidence for the clinical diagnosis and prognosis of ischemic stroke.
Keywords: Magnetic resonance imaging, Angiography, Ischemic stroke, NaGdF4, Multimodal imaging
Full Text:
PDFReferences
Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023. Chin J Neurol, 2024, 57(6): 523-559. doi: 10.3760/cma.j.cn113694-20240410-00221.
KLEINDORFER D O, TOWFIGHI A, CHATURVEDI S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association/American stroke association. Stroke, 2021, 52(7): e364-e467. doi: 10.1161/STR.0000000000000375.
HERPICH F, RINCON F. Management of acute ischemic stroke. Crit Care Med, 2020, 48(11): 1654-1663. doi: 10.1097/CCM.00000000 00004597.
ZHANG L J, WEN K, WANG Y, et al. Analysis of the mediating effect of fatigue between social support and depression in hospitalized patients with ischemic stroke. J Sichuan Univ (Med Sci), 2024, 55(5): 1226-1231. doi: 10.12182/20240960506.
HE J, WANG F, XIONG L L, et al. The occurrence and risk factors of stroke complicated by venous thromboembolism. J Sichuan Univ (Med Sci), 2023, 54(3): 638-641. doi: 10.12182/20230560104.
MAGUIDA G, SHUAIB A. Collateral circulation in ischemic stroke: an updated review. J Stroke, 2023, 25(2): 179-198. doi: 10.5853/jos.2022.02936.
FUKUDA K A, LIEBESKIND D S. Evaluation of collateral circulation in patients with acute ischemic stroke. Radiol Clin, 2023, 61(3): 435-443. doi: 10.1016/j.rcl.2023.01.002.
YI Y, LIU Z, WANG M, et al. Penumbra in acute ischemic stroke. Curr Neurovasc Res, 2021, 18(5): 572-585. doi: 10.2174/15672026196662 11231094046.
PACIARONI M, CASO V, AGNELLI G. The concept of ischemic penumbra in acute stroke and therapeutic opportunities. Eur Neurol, 2009, 61(6): 321-330. doi: 10.1159/000210544.
SOLOMON C G, POWERS W J. Acute ischemic stroke. New Engl J Med, 2020, 383(3): 252-260. doi: 10.1056/NEJMcp1917030.
PATEL S D, LIEBESKIND D. Collaterals and elusive ischemic penumbra. Transl Stroke Res, 2023, 14(1): 3-12. doi: 10.1007/s12975-022-01116-2.
UNIKEN VENEMA S M, DANKBAAR J W, Van der LUGT A, et al. Cerebral collateral circulation in the era of reperfusion therapies for acute ischemic stroke. Stroke, 2022, 53(10): 3222-3234. doi: 10.1161/STROKEAHA.121.037869.
TSUI B, NOUR M, CHEN I, et al. MR angiography in assessment of collaterals in patients with acute ischemic stroke: a comparative analysis with digital subtraction angiography. Brain Sci, 2022, 12(9): 1181. doi: 10. 3390/brainsci12091181.
TEDYANTO E H, TINI K, PRAMANA N A K. Magnetic resonance imaging in acute ischemic stroke. Cureus, 2022, 14(7): e27224. doi: 10. 7759/cureus.27224.
GOYAL M, OSPEL J M, MENON B, et al. Challenging the ischemic core concept in acute ischemic stroke imaging. Stroke, 2020, 51(10): 3147-3155. doi: 10.1161/STROKEAHA.120.030620.
MORITANI T, CAPIZZANO A A. Diffusion-weighted MR imaging of the brain, head and neck, and spine. Springer International Publishing: Cham, 2021: 113-154.
SCAGLIONE M, ÇALLI C, MUTO M, et al. Toxic–metabolic encephalopathies. In: Emergency radiology of the head and spine. Springer International Publishing: Cham, 2022: 215-233.
WANG T, HOU Y, BU B, et al. Timely visualization of the collaterals formed during acute ischemic stroke with Fe3O4 nanoparticle-based MR imaging probe. Small, 2018, 14(23): 1800573. doi: 10.1002/smll. 201800573.
ZHANG P S, LI W Y, LIU C, et al. Simultaneous identifying the infarct core, collaterals, and penumbra after acute ischemic stroke with a low-immunogenic MRI nanoprobe. Mater Design, 2023, 233: 112211. doi: 10. 1016/j.matdes.2023.112211.
HAN B, ZHAO Y, MA L, et al. A minimalist iron oxide nanoprobe for the high-resolution depiction of stroke by susceptibility-weighted imaging. Small, 2024, 20(44): 2401061. doi: 10.1002/smll.202401061.
ZHANG P S, CHENG J W, LU Y J, et al. Hypersensitive MR angiography based on interlocking stratagem for diagnosis ofcardiac-cerebral vascular diseases. Nat Commun, 2023, 14(1): 6149. doi: 10.1038/s41467-023- 41783-9.
HOU Y, QIAO R R, FANG F, et al. NaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivo. ACS Nano, 2013, 7(1): 330-338. doi: 10.1021/nn304837c.
ZHANG P S, FENG Y C, ZHU L C, et al. Predicting thrombolytic haemorrhage risk of acute ischemic stroke through angiogenesis/inflammation dual-targeted MR imaging. Nano Today, 2023, 48: 101707. doi: 10.1016/j.nantod.2022.101707.
ZHANG P S, CHENG J W, LIU C, et al. Hypersensitive MR angiography for diagnosis of ischemic stroke and reperfusion subarachnoid hemorrhage. Anal Chem, 2024, 96(29): 11742-11750. doi: 10.1021/acs. analchem.4c01097.
LI W Y, CHENG J W, LIU C, et al. Shine and darkle the blood vessels: multiparameter hypersensitive MR angiography for diagnosis of panvascular diseases. Sci Adv, 2024, 10: eadq4082. doi: 10.1126/sciadv. adq4082.
Refbacks
- There are currently no refbacks.
